Tijana Jovanovic-Talisman, PhD, is an Associate Professor at Beckman Research Institute at City of Hope and a 2025 NETRF Pilot Award grantee for her research
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Scientists are discovering that where a tumor grows in the body may influence how it behaves.
For many families affected by neuroendocrine cancer, supporting research becomes a deeply personal mission. For Wayne Firsty and his children, Shay and Alana, that commitment
Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and
More than one thousand neuroendocrine cancer researchers, physicians, and patient advocates from over 50 countries gathered this month in Krakow, Poland, for the 23rd Annual
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new open-access review article in Virchows Archiv, “Novel concepts of cell-of-origin in neuroendocrine neoplasms,” by
Jamie Metzl is a writer and technology/health care futurist who regularly speaks to the medical industry on the future of health care. When Jamie’s father,
The Neuroendocrine Tumor Research Foundation (NETRF) today announced its latest round of neuroendocrine cancer research grant recipients. The thirteen investigators receiving awards are pursuing innovative,
The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to share an important leadership transition within our Board of Scientific Advisors (BOSA), a group of distinguished
Highlights from recent clinical trial developments in neuroendocrine cancer Neuroendocrine cancer research continues to evolve, with a growing number of clinical trials exploring bold, highly